Status:
COMPLETED
Incidence of COVID-19 Test Conversion in Post-surgical Patients
Lead Sponsor:
Northwell Health
Conditions:
Sars-CoV2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The current Sars-CoV-2 (COVID-19) pandemic has created major changes in how physicians perform routine healthcare for our patients, including elective and non-elective surgical procedures. Beginning o...
Detailed Description
The rapid spread of the COVID-19 infection has led to a near global lockdown including a pause in all elective surgeries \[1-6\]. Multiple healthcare systems and surgical societies recommended ceasing...
Eligibility Criteria
Inclusion
- Patients of any ethnic background undergoing an elective surgical procedure with a minimum of 24-hour hospital admission.
- Age ≥18.
- Written Voluntary Informed Consent.
Exclusion
- Patients age \< 18 years.
- Prior documented COVID-19 Infection.
- Current hospital inpatient prior to procedure.
- Person Under Investigation for COVID-19 infection.
- Current use of antiviral medications.
- Severe or uncontrolled, concurrent medical disease (e.g. uncontrolled diabetes, unstable angina, myocardial infarction within 6 months, congestive heart failure, etc.) .
- Documented immunodeficiency.
- Patients with dementia or altered mental status that would prohibit the giving and understanding of informed consent at the time of study entry.
- Outpatient procedures with planned same-day discharge.
Key Trial Info
Start Date :
May 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 4 2020
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT04392323
Start Date
May 13 2020
End Date
October 4 2020
Last Update
November 8 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
North Shore University Hospital
Manhasset, New York, United States, 10030
2
Long Island Jewish Medical Center
New Hyde Park, New York, United States, 11040